Insider Buying: Johnson Matthey (LON:JMAT) Insider Buys £100,495.98 in Stock

Johnson Matthey PLC (LON:JMATGet Free Report) insider Liam Condon acquired 5,226 shares of Johnson Matthey stock in a transaction on Monday, February 23rd. The stock was acquired at an average price of GBX 1,923 per share, with a total value of £100,495.98.

Liam Condon also recently made the following trade(s):

  • On Wednesday, February 11th, Liam Condon bought 10 shares of Johnson Matthey stock. The shares were acquired at an average price of GBX 2,342 per share, for a total transaction of £234.20.
  • On Tuesday, January 13th, Liam Condon purchased 10 shares of Johnson Matthey stock. The stock was bought at an average cost of GBX 2,321 per share, for a total transaction of £232.10.
  • On Wednesday, December 10th, Liam Condon purchased 14 shares of Johnson Matthey stock. The shares were bought at an average price of GBX 2,013 per share, with a total value of £281.82.

Johnson Matthey Stock Performance

LON JMAT opened at GBX 2,000 on Friday. The company has a market capitalization of £3.35 billion, a PE ratio of -30.35, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45. Johnson Matthey PLC has a 52-week low of GBX 1,131 and a 52-week high of GBX 2,434. The company has a 50-day simple moving average of GBX 2,265.63 and a 200 day simple moving average of GBX 2,098.46.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on JMAT shares. Berenberg Bank dropped their price objective on Johnson Matthey from GBX 2,100 to GBX 2,050 and set a “hold” rating on the stock in a research note on Tuesday, November 25th. Panmure Gordon restated a “buy” rating and issued a GBX 2,370 target price on shares of Johnson Matthey in a research note on Monday, November 24th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Johnson Matthey from GBX 2,300 to GBX 2,400 and gave the company a “buy” rating in a research report on Wednesday, January 21st. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of GBX 2,268.

Read Our Latest Research Report on Johnson Matthey

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

See Also

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.